{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:35:03Z","timestamp":1793745303471,"version":"4.6.1"},"reference-count":39,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec id=\"ab-coi230058-4\"><jats:title>Importance<\/jats:title><jats:p>The revised 2021 US Preventive Services Task Force (USPSTF) guidelines for lung cancer screening have been shown to reduce disparities in screening eligibility and performance between African American and White individuals vs the 2013 guidelines. However, potential disparities across other racial and ethnic groups in the US remain unknown. Risk model\u2013based screening may reduce racial and ethnic disparities and improve screening performance, but neither validation of key risk prediction models nor their screening performance has been examined by race and ethnicity.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-5\"><jats:title>Objective<\/jats:title><jats:p>To validate and recalibrate the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial 2012 (PLCOm2012) model\u2014a well-established risk prediction model based on a predominantly White population\u2014across races and ethnicities in the US and evaluate racial and ethnic disparities and screening performance through risk-based screening using PLCOm2012 vs the USPSTF 2021 criteria.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>In a population-based cohort design, the Multiethnic Cohort Study enrolled participants in 1993-1996, followed up through December 31, 2018. Data analysis was conducted from April 1, 2022, to May 19. 2023. A total of 105\u202f261 adults with a smoking history were included.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-7\"><jats:title>Exposures<\/jats:title><jats:p>The 6-year lung cancer risk was calculated through recalibrated PLCOm2012 (ie, PLCOm2012-Update) and screening eligibility based on a 6-year risk threshold greater than or equal to 1.3%, yielding similar eligibility as the USPSTF 2021 guidelines.<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-8\"><jats:title>Outcomes<\/jats:title><jats:p>Predictive accuracy, screening eligibility-incidence (E-I) ratio (ie, ratio of the number of eligible to incident cases), and screening performance (sensitivity, specificity, and number needed to screen to detect 1 lung cancer).<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-9\"><jats:title>Results<\/jats:title><jats:p>Of 105\u202f261 participants (60 011 [57.0%] men; mean [SD] age, 59.8 [8.7] years), consisting of 19\u202f258 (18.3%) African American, 27\u202f227 (25.9%) Japanese American, 21\u202f383 (20.3%) Latino, 8368 (7.9%) Native Hawaiian\/Other Pacific Islander, and 29\u202f025 (27.6%) White individuals, 1464 (1.4%) developed lung cancer within 6 years from enrollment. The PLCOm2012-Update showed good predictive accuracy across races and ethnicities (area under the curve, 0.72-0.82). The USPSTF 2021 criteria yielded a large disparity among African American individuals, whose E-I ratio was 53% lower vs White individuals (E-I ratio: 9.5 vs 20.3; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001). Under the risk-based screening (PLCOm2012-Update 6-year risk \u22651.3%), the disparity between African American and White individuals was substantially reduced (E-I ratio: 15.9 vs 18.4; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001), with minimal disparities observed in persons of other minoritized groups, including Japanese American, Latino, and Native Hawaiian\/Other Pacific Islander. Risk-based screening yielded superior overall and race and ethnicity\u2013specific performance to the USPSTF 2021 criteria, with higher overall sensitivity (67.2% vs 57.7%) and lower number needed to screen (26 vs 30) at similar specificity (76.6%).<\/jats:p><\/jats:sec><jats:sec id=\"ab-coi230058-10\"><jats:title>Conclusions<\/jats:title><jats:p>The findings of this cohort study suggest that risk-based lung cancer screening can reduce racial and ethnic disparities and improve screening performance across races and ethnicities vs the USPSTF 2021 criteria.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoncol.2023.4447","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T15:32:42Z","timestamp":1698334362000},"page":"1640","source":"Crossref","is-referenced-by-count":65,"title":["Risk Model\u2013Based Lung Cancer Screening and Racial and Ethnic Disparities in the US"],"prefix":"10.1001","volume":"9","author":[{"given":"Eunji","family":"Choi","sequence":"first","affiliation":[{"name":"Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria Y.","family":"Ding","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia J.","family":"Luo","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"ten Haaf","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie T.","family":"Wu","sequence":"additional","affiliation":[{"name":"Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline V.","family":"Aredo","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne R.","family":"Wilkens","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D.","family":"Freedman","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah M.","family":"Backhus","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann N.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Radiology, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Meza","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Lui","sequence":"additional","affiliation":[{"name":"Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A.","family":"Haiman","sequence":"additional","affiliation":[{"name":"Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Shim Lani","family":"Park","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Le Marchand","sequence":"additional","affiliation":[{"name":"Cancer Epidemiology Program, University of Hawaii Cancer Center, Honolulu, Hawaii"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel W.","family":"Neal","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather A.","family":"Wakelee","sequence":"additional","affiliation":[{"name":"Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California"},{"name":"Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Tammem\u00e4gi","sequence":"additional","affiliation":[{"name":"Department of Health Sciences, Brock University, St Catharines, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer S.","family":"Han","sequence":"additional","affiliation":[{"name":"Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Neurosurgery, Stanford University School of Medicine, Stanford, California"},{"name":"Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California"},{"name":"Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"coi230058r1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.v72.1","article-title":"Cancer statistics, 2022.","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"coi230058r2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","article-title":"Reduced lung-cancer mortality with low-dose computed tomographic screening.","volume":"365","author":"Aberle","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"coi230058r3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced lung-cancer mortality with volume CT screening in a randomized trial.","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"coi230058r4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7326\/M13-2316","article-title":"Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the US Preventive Services Task Force.","volume":"160","author":"de Koning","year":"2014","journal-title":"Ann Intern Med"},{"issue":"5","key":"coi230058r5","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement.","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"10","key":"coi230058r6","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1001\/jama.2021.1117","article-title":"Screening for lung cancer: US Preventive Services Task Force recommendation statement.","volume":"325","author":"Krist","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"coi230058r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.28176","article-title":"Evaluation of population-level changes associated with the 2021 US Preventive Services Task Force lung cancer screening recommendations in community-based health care systems.","volume":"4","author":"Ritzwoller","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"coi230058r8","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1001\/jamaoncol.2021.6720","article-title":"Comparison between the 2021 USPSTF lung cancer screening criteria and other lung cancer screening criteria for racial disparity in eligibility.","volume":"8","author":"Pu","year":"2022","journal-title":"JAMA Oncol"},{"issue":"3","key":"coi230058r9","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkac033","article-title":"Racial and ethnic disparities in lung cancer screening by the 2021 USPSTF guidelines versus risk-based criteria: the Multiethnic Cohort Study.","volume":"6","author":"Aredo","year":"2022","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"1","key":"coi230058r10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.chest.2021.06.066","article-title":"Addressing sex disparities in lung cancer screening eligibility: USPSTF vs PLCOm2012 criteria.","volume":"161","author":"Pasquinelli","year":"2022","journal-title":"Chest"},{"issue":"3","key":"coi230058r11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1148\/radiol.2021204691","article-title":"Racial and ethnic disparities in lung cancer screening eligibility.","volume":"301","author":"Narayan","year":"2021","journal-title":"Radiology"},{"issue":"9","key":"coi230058r12","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/cncr.v128.9","article-title":"Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.","volume":"128","author":"Williams","year":"2022","journal-title":"Cancer"},{"issue":"1","key":"coi230058r13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.33769","article-title":"Evaluation of revised US Preventive Services Task Force lung cancer screening guideline among women and racial\/ethnic minority populations.","volume":"4","author":"Reese","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"coi230058r14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/jnci\/djz164","article-title":"A comparative modeling analysis of risk-based lung cancer screening strategies.","volume":"112","author":"Ten Haaf","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"coi230058r15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/jnci\/djz165","article-title":"Basing eligibility for lung cancer screening on individualized risk calculators should save more lives, but life expectancy matters.","volume":"112","author":"Katki","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"coi230058r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.0204","article-title":"Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: a secondary analysis of data from the National Lung Screening Trial.","volume":"2","author":"Tammem\u00e4gi","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"12","key":"coi230058r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001764","article-title":"Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts.","volume":"11","author":"Tammem\u00e4gi","year":"2014","journal-title":"PLoS Med"},{"issue":"8","key":"coi230058r18","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1016\/j.jtho.2017.04.021","article-title":"The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency.","volume":"12","author":"Cressman","year":"2017","journal-title":"J Thorac Oncol"},{"issue":"11","key":"coi230058r19","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1093\/jnci\/djaa013","article-title":"Disparities of national lung cancer screening guidelines in the US population.","volume":"112","author":"Han","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"coi230058r20","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1093\/jnci\/djaa211","article-title":"Using prediction models to reduce persistent racial and ethnic disparities in the draft 2020 USPSTF lung cancer screening guidelines.","volume":"113","author":"Landy","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"coi230058r21","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.chest.2021.01.070","article-title":"Potential disparities by sex and race or ethnicity in lung cancer screening eligibility rates.","volume":"160","author":"Pinsky","year":"2021","journal-title":"Chest"},{"issue":"11","key":"coi230058r22","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S1470-2045(17)30597-1","article-title":"Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.","volume":"18","author":"Tammemagi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"4","key":"coi230058r23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002277","article-title":"Risk prediction models for selection of lung cancer screening candidates: a retrospective validation study.","volume":"14","author":"Ten Haaf","year":"2017","journal-title":"PLoS Med"},{"issue":"8","key":"coi230058r24","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1056\/NEJMoa1211776","article-title":"Selection criteria for lung-cancer screening.","volume":"368","author":"Tammem\u00e4gi","year":"2013","journal-title":"N Engl J Med"},{"issue":"1","key":"coi230058r25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2019-000455","article-title":"LDCT lung cancer screening in populations at different risk for lung cancer.","volume":"7","author":"Teles","year":"2020","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"coi230058r26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S1470-2045(21)00590-8","article-title":"USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort study.","volume":"23","author":"Tammem\u00e4gi","year":"2022","journal-title":"Lancet Oncol"},{"issue":"21","key":"coi230058r27","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1001\/jama.2016.6255","article-title":"Development and validation of risk models to select ever-smokers for CT lung cancer screening.","volume":"315","author":"Katki","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"coi230058r28","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/jnci\/95.6.470","article-title":"Variations in lung cancer risk among smokers.","volume":"95","author":"Bach","year":"2003","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"coi230058r29","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/jnci\/djj163","article-title":"Validation of a model of lung cancer risk prediction among smokers.","volume":"98","author":"Cronin","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"coi230058r30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1136\/thoraxjnl-2020-215158","article-title":"Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation.","volume":"76","author":"Field","year":"2021","journal-title":"Thorax"},{"issue":"4","key":"coi230058r31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/oxfordjournals.aje.a010213","article-title":"A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics.","volume":"151","author":"Kolonel","year":"2000","journal-title":"Am J Epidemiol"},{"issue":"10","key":"coi230058r32","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1001\/jama.2021.1077","article-title":"Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: modeling study for the US Preventive Services Task Force.","volume":"325","author":"Meza","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"coi230058r33","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.athoracsur.2020.07.051","article-title":"Organized lung cancer screening pilot: informing a province-wide program in Ontario, Canada.","volume":"111","author":"Darling","year":"2021","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"coi230058r34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.2307\/2531094","article-title":"The analysis of rates using Poisson regression models.","volume":"39","author":"Frome","year":"1983","journal-title":"Biometrics"},{"issue":"7","key":"coi230058r35","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data.","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"6","key":"coi230058r36","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/aje\/kwaa044","article-title":"Estimating risk ratios and risk differences using regression.","volume":"189","author":"Naimi","year":"2020","journal-title":"Am J Epidemiol"},{"issue":"10","key":"coi230058r37","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers\u2014a different disease.","volume":"7","author":"Sun","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"coi230058r38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41698-018-0057-y","article-title":"Tobacco biomarkers and genetic\/epigenetic analysis to investigate ethnic\/racial differences in lung cancer risk among smokers.","volume":"2","author":"Murphy","year":"2018","journal-title":"NPJ Precis Oncol"},{"issue":"2","key":"coi230058r39","first-page":"103","article-title":"Ethnic differences in the lung cancer risk associated with smoking.","volume":"1","author":"Le Marchand","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2811044\/jamaoncology_choi_2023_oi_230058_1702491805.12234.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:02:14Z","timestamp":1703174534000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2811044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2023.4447","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}